Table:
begin	end	state
1	11	non-cytoplasmic
12	30	transmembrane
31	50	cytoplasmic
51	71	transmembrane
72	90	non-cytoplasmic
91	111	transmembrane
112	139	cytoplasmic
140	160	transmembrane
161	171	non-cytoplasmic
172	193	transmembrane
194	204	cytoplasmic
205	226	transmembrane
227	231	non-cytoplasmic
232	255	transmembrane
256	295	cytoplasmic
296	317	transmembrane
318	353	non-cytoplasmic
354	375	transmembrane
376	387	cytoplasmic
388	409	transmembrane
410	414	non-cytoplasmic
415	437	transmembrane
438	497	cytoplasmic

Input:
>WP_104486271.1 NCBI__GCF_002936955.1:WP_104486271.1
MSDLVNGINSYIWSLPLIYLCLGVGLYFSLRTRFLQIRHIKEMVRLMFKGEASPAGITSF
QALTLSLSGRVGTGNIAGVATAITFGGPGAVFWMWMVAFLGAGTAFVESTLAQIYKEKDD
NGLYRGGPAYYIEKGLGMKWYAWTFAFATIIGCGLLLPGVQANSIASGIENAFGISTSVS
AAVVVVLLGLIIFGGVKRIAHFTQIVVPFMALGYILVAFVVIAMHIEMLPDVVGLIVGSA
FGMKAGFGAILGLAIEWGVKRGIYSNEAGQGTGPHPAAAAEVSHPAKQGLVQGFSVYVDT
LFVCTATAFMIIITGAYNVMGKAGEVIVEQLPGVSAGPGYTQAAVESVMPGFGGTFVAVA
LFFFAFTTILAYYYIAETNVAYINRHIHRPWMIFVLKIALMASVVYGSVKTAELAWGLGD
IGVGMMAWLNIVAILLLQKPALIALKDYEAQKAQGLDPTFDPIKLGIKNADIWVKDKKAK
TDAATDAVVTDAQAERG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server